Regulatory Status of CBD in Europe
In Europe, the regulatory status of CBD is determined by the European Union (EU) and its member states. The EU Novel Food Catalogue considers CBD as a novel food ingredient, requiring authorization before it can be legally marketed. This means that CBD products, including extracts, isolates, and CBD-infused foods or beverages, must undergo a safety assessment and receive approval from the European Food Safety Authority (EFSA).
The Novel Food Regulation was introduced to ensure the safety of new and innovative food products, including those containing CBD. It requires manufacturers to provide scientific evidence demonstrating the safety of the product, including information on the production process, composition, and potential risks. This process can be time-consuming and costly for businesses looking to enter the CBD market.
While the Novel Food Regulation applies across the EU, member states can have additional regulations or interpretations of the rules. Some countries, such as France, Germany and Austria, have implemented specific regulations that allow CBD products with certain THC thresholds (usually below 0.2%) to be sold as food supplements. These regulations may also include labeling requirements and restrictions on advertising claims.
However, it is important to note that other EU countries may have stricter interpretations of the Novel Food Regulation, considering all CBD products as novel foods and therefore requiring authorization before marketing.
Additionally, the EU is in the process of considering potential changes to the regulation of CBD.